Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT02679638 Not yet recruiting - Breast Cancer Clinical Trials

Factors and Perceptions Affecting Treatment Choices of Breast Cancer Patients

Start date: February 2016
Phase: N/A
Study type: Observational

A Multi-center Cross-sectional quantitative study with a preliminary qualitative study part aiming to identify and analyze demand factors, supply factors and perceptions affecting Breast Cancer patients' treatment choices of Breast Cancer patients in 5 key decision points: participation role in the decision making process, hospital choice, treatment regimen choice, surgical extent and surgeon choice. 25 patients and caregivers will participate in the qualitative part and 425 Israeli Breast Cancer patients will participate in the quantitative study.

NCT ID: NCT02670668 Not yet recruiting - Breast Cancer Clinical Trials

Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer

Start date: January 2016
Phase: N/A
Study type: Interventional

The study is to determine the prevalence of potential chemo-response related genes mutation in TNBC patients between pCR and SD/PD group, which achieved after NAC; and to evaluate potential relationship between these gene mutations and NAC-response in TNBC patients.Based on the results,we can further characterize TNBC from a phenotypical and molecular perspective, in order to identify potential new target agents and to individualize the treatment.

NCT ID: NCT02617264 Not yet recruiting - Breast Cancer Clinical Trials

Spot tm Tattooing of Biopsied Axillary Lymph Nodes With Ultrasound Guided in Breast Cancer Patients Prior to Surgery

Start date: January 2016
Phase: N/A
Study type: Interventional

To assess feasibility and clinical utility of marking biopsied axillary lymph nodes with Spot at time of biopsy.

NCT ID: NCT02593890 Not yet recruiting - Breast Cancer Clinical Trials

Breast Surgery Recovery: The Clinical and Psychosocial Impact of THEYA Recovery Range

Start date: November 2015
Phase: N/A
Study type: Interventional

A randomised interventional comparative control study will be undertaken to compare the THEYA Recovery Range postoperatively for patients undergoing wider lumpectomies, partial mastectomies and total mastectomies to current practice using a mixed method combining quantitative and qualitative instruments. 100 female participants are hoped to be recruited following breast surgery after a newly diagnosed breast cancer. This study will answer the research question:- "What is the clinical and psychosocial impact of the THEYA Recovery Range in comparison to recommended practice during and after breast cancer treatment?" This study will leverage the findings of a pilot study conducted by Applied Research Connected Healthcare (ARCH) measuring the usability of the THEYA Recovery Range. This study aims to assess the participants' experience of recovery in the immediate post-operative period and the psychosocial effect of THEYA Recovery Range in comparison to current recommended practice.

NCT ID: NCT02583204 Not yet recruiting - Breast Cancer Clinical Trials

Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of Interventions

Start date: October 2015
Phase: N/A
Study type: Interventional

The study compares three strategies to prevent/minimise nail problems occuring in women, with breast cancer, undergoing Taxane chemotherapy. The strategies are: application of nail polish and normal care; application of Onicolife drops and normal care and; normal care only.

NCT ID: NCT02517086 Not yet recruiting - Breast Cancer Clinical Trials

Vascular Changes Due to Different Treatments of Lymphedema Secondary to Postoperative Breast Cancer

Start date: August 2015
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the effect of elastic compression, functional compressive bandaging (ECF) and active exercises in the bloodstream of the upper member ipsilateral to the surgical procedure for the treatment of breast cancer.

NCT ID: NCT02493569 Not yet recruiting - Breast Cancer Clinical Trials

A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China

Start date: October 2016
Phase: N/A
Study type: Observational

The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

NCT ID: NCT02488603 Not yet recruiting - Breast Cancer Clinical Trials

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

Start date: August 2015
Phase: N/A
Study type: Interventional

This is an educational intervention study for breast cancer patients who undergo tamoxifen treatment. The purpose of the study is to assess the impact of decision aids (DA) on the patients' decision-making process, compliance on drug, and knowledge regarding tamoxifen treatment. Patients will randomly assign to DA group or conventional group. Both groups will have baseline questionnaire surveys before starting tamoxifen treatment, and 4 weeks later follow-up questionnaire surveys.

NCT ID: NCT02464774 Not yet recruiting - Breast Cancer Clinical Trials

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Start date: July 2015
Phase: N/A
Study type: Interventional

RATIONALE: Triple-negative breast cancer (TNBC) is an aggressive subtype shown to have a high risk of locoregional recurrence (LRR) and distant metastasis (DM). The equivalent impact of breast-conserving therapy (BCT) and mastectomy on disease-free survival in patients with early breast cancer has been established by a number of large randomized controlled trials and meta-analysis. However, ongoing dispute exists on whether TNBC is a good candidate for BCT. PURPOSE: This prospective, randomized, open, single-center Phase III clinical study is conducted to compare efficacy and safety of breast-conserving therapy and mastectomy in treating Chinese patients with early TNBC.

NCT ID: NCT02448576 Not yet recruiting - Breast Cancer Clinical Trials

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

Start date: August 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare whether prophylactic cranial irradiation in patients with advanced triple negative breast cancer who had a response to first line chemotherapy could prolong brain-metastasis free survival.